Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Curr Neurovasc Res ; 5(3): 171-7, 2008 Aug.
Article in English | MEDLINE | ID: mdl-18691074

ABSTRACT

Intracerebral hemorrhage (ICH) was widely believed to be a monophasic event whereby cell death occurs from the initial space-occupying effects of the hematoma. However, we now know that secondary degenerative events contribute to delayed cell death, functional impairment and clinical deterioration. In three experiments, we further characterized the long-term maturation of injury in the collagenase model of striatal ICH in rat. First, we quantified the volume of tissue lost from 7 to 60 days showing that tissue loss more than doubled over this time. As the volume of tissue lost does not distinguish gray from white matter damage, gold chloride staining was used in a second experiment in ICH rats that survived 7 or 60 days. The mid-sagittal area of the corpus callosum significantly declined (22%) over this period, whereas the hippocampal and anterior commissures were not affected. A third experiment used the Golgi-Cox stain to examine dendritic arborization of peri-hematoma and contralateral medium spiny neurons of the striatum. We found an early and sustained increase in dendritic arborization in the non-lesioned hemisphere, whereas there was initial atrophy of peri-hematoma striatal neurons that eventually recovered to normal. These findings show that tissue loss, including white matter atrophy, continues over extended periods after ICH making it a potential target for cytoprotective agents. Finally, the dendritic alterations in both ipsi- and contralateral striatal neurons likely influence spontaneous recovery and are potential targets to further improve it.


Subject(s)
Cerebral Hemorrhage/complications , Dendrites/pathology , Nerve Degeneration/etiology , Nerve Degeneration/pathology , Animals , Atrophy/etiology , Atrophy/pathology , Atrophy/physiopathology , Cerebral Arteries/drug effects , Cerebral Arteries/pathology , Cerebral Arteries/physiopathology , Cerebral Hemorrhage/chemically induced , Collagenases , Coloring Agents , Corpus Callosum/pathology , Corpus Callosum/physiopathology , Corpus Striatum/pathology , Corpus Striatum/physiopathology , Disease Models, Animal , Disease Progression , Gold Compounds , Male , Nerve Degeneration/physiopathology , Nerve Fibers, Myelinated/pathology , Rats , Rats, Sprague-Dawley , Silver Staining , Staining and Labeling
2.
J Cereb Blood Flow Metab ; 26(8): 1031-42, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16395282

ABSTRACT

Successful clinical translation of prospective cytoprotectants will likely occur only with treatments that improve functional recovery in preclinical (rodent) studies. Despite this assumption, many rely solely on histopathologic end points or the use of one or two simple behavioral tests. Presently, we used a battery of tests to gauge recovery after a unilateral intracerebral hemorrhagic stroke (ICH) targeting the striatum. In total, 60 rats (N=15 per group) were stereotaxically infused with 0 (SHAM), 0.06 (MILD lesion), 0.12 (MODERATE lesion), or 0.18 U (SEVERE lesion) of bacterial collagenase. This created a range of injury akin to moderate (from SEVERE to MODERATE or MODERATE to MILD lesion size approximately 30% reduction) and substantial cytoprotection (SEVERE to MILD lesion size--51% reduction). Post-ICH functional testing occurred over 30 days. Tests included the horizontal ladder and elevated beam tests, swimming, limb-use asymmetry (cylinder) test, a Neurologic Deficit Scale, an adhesive tape removal test of sensory neglect, and the staircase and single pellet tests of skilled reaching. Most tests detected significant impairments (versus SHAM), but only a few (e.g., staircase) frequently distinguished among ICH groups and none consistently differentiated among all ICH groups. However, by using a battery of tests we could behaviorally distinguish groups. Thus, preclinical testing would benefit from using a battery of behavioral tests as anything less may miss treatment effects. Such testing must be based on factors including the type of lesion, the postoperative delay and the time required to complete testing.


Subject(s)
Behavior, Animal , Cerebral Hemorrhage/pathology , Cerebral Hemorrhage/physiopathology , Cytoprotection , Recovery of Function , Animals , Bacterial Proteins/pharmacology , Bacterial Proteins/toxicity , Cerebral Hemorrhage/chemically induced , Collagenases/pharmacology , Collagenases/toxicity , Disease Models, Animal , Exercise Test , Male , Rats , Rats, Sprague-Dawley
SELECTION OF CITATIONS
SEARCH DETAIL
...